Drugs / NVP-2203
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05856487 | Jun 2023 → May 2024 | cardiovascular disorder | NVP Healthcare | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-2203 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05856487 ↗ |